Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) Shareholder Notice: Investigation of Takeover

San Diego, CA -- (ReleaseWire) -- 06/29/2015 -- An investigation on behalf of investors, who currently hold shares of Kythera Biopharmaceuticals Inc (NASDAQ:KYTH), was announced concerning whether the takeover of Kythera Biopharmaceuticals Inc by Allergan plc for a value of $75 per share is unfair to NASDAQ:KYTH stockholders.